Warning letter
Dakota Laboratories, Llc [ARCHIVED]: warning letter of Mar 17, 2011
FDA warning letter 131410 · Minneapolis District Office
Key facts
| Reference number | 131410 |
|---|---|
| Company | Dakota Laboratories, Llc [ARCHIVED] |
| Subject | CGMP for Finished Pharmaceuticals/Adulterated |
| Issue date | Mar 17, 2011 |
| Posted date | Mar 17, 2011 |
| Issuing office | Minneapolis District Office |
| Product type | Drugs |
| CFR sections cited | 211.111, 211.113(b), 211.42(c)(10)(iv), 211.192 |
| Inspection city | Mitchell |
| Inspection ZIP | 57301 |
| Inspection start date | Jun 22, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: